Amphastar Pharmaceuticals Inc Sustainability Reports
Amphastar Pharmaceuticals, Inc. develops, manufactures, and markets generic and proprietary injectable, inhalation, and intranasal products. The company targets complex drug formats to provide critical therapeutic options to patients.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
LEI: 54930055TH0ZLSAQMJ38
FIGI: BBG001SCM4W2
11 reports from 2014 to 2025
